Claritev (CTEV) Non-Current Deffered Revenue (2020)

Claritev (CTEV) posted quarterly Non-Current Deffered Revenue of $38.5 million for Q3 2020, little changed quarter-over-quarter from $38.5 million in Q2 2020.

Claritev (CTEV) Non-Current Deffered Revenue (2020) Analysis & Trends

Claritev's Non-Current Deffered Revenue history runs 1 years deep, the most recent figure standing at $38.5 million for Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 5.02 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 9.68 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 6.75 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 37,000.00
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Claritev 645.93 Mn 624.98 Mn 189.81 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 38.50 Mn
Jun 30, 2020 38.50 Mn
Mar 31, 2020 38.50 Mn